Print this page    •   Back to Web version of article

Medical News
Gilead Becomes First Company to License Drugs to Medicines Patent Pool

July 12, 2011

"In the first agreement between a pharmaceutical company and the new international Medicines Patent Pool, Gilead Sciences announced Tuesday that it would license four of its AIDS and hepatitis B drugs to the pool," the New York Times reports (McNeil, 7/12).

Under the agreement, several generic drug manufacturers will be allowed to make low-cost versions of the medications tenofovir and emtricitabine; two drugs that are still in clinical development, cobicistat and elvitegravir; and an experimental combination pill of all four of these drugs, known as the Quad, Agence France-Presse writes. The deal "is unusual because pharmaceutical companies very rarely allow licensing of drugs for public health while the product is still in clinical development," according to the news agency (7/12).

"Ellen 't Hoen, the pool's executive director, told Reuters she was negotiating terms for similar deals with ViiV Healthcare -- a GlaxoSmithKline and Pfizer joint venture -- as well as with Bristol-Myers Squibb, Roche, Boehringer Ingelheim and Sequoia Pharmaceuticals" (Hirschler, 7/12).

Back to other news for July 2011

This information was reprinted from with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.